Pharmacokinetic Comparability of Benralizumab using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers

Trial Identifier: D3250C00030
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT02968914
Start Date: January 2017
Primary Completion Date: July 2017
Study Completion Date: July 2017
Condition: Asthma; Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050
Germany Harrow, Germany, HA1 3UJ